Extracellular vesicles for cardiovascular therapeutics
In this landmark review, group da Costa Martins and collaborators outline the endogenous properties of EVs that make them natural delivery agents as well as the features that can be improved by bioengineering.
We also discuss the therapeutic applications of native and bioengineered EVs to cardiovascular diseases and examine the opportunities and challenges that need to be addressed to advance this research area, with an emphasis on clinical translation.
Extracellular vesicles are a heterogeneous group of natural particles that are relevant to the treatment of cardiovascular diseases. These endogenous vesicles have certain properties that allow them to survive in the extracellular space, bypass biological barriers and deliver their biologically active molecular cargo to recipient cells. Moreover, EVs can be bioengineered to increase their stability, bioactivity, presentation to acceptor cells and capacity for on-target binding at both cell-type-specific and tissue-specific levels.
Also read
-
MaaSec – The Netherlands' Only Active ACM Student Chapter captures the flag
In January, a group of Computer Science students at Maastricht University launched MaaSec, currently the only active ACM student chapter in the Netherlands. And in just a few months, they've already made a name for themselves; especially in the world of Capture the Flag (CTF) competitions.
-
Publication of the National Vision on Sustainable Carbon in the Chemical Industry
On April 22, the National Vision on Sustainable Carbon in the Chemical Industry was published for public consultation.
-
Municipality of Heerlen, Parkstad Urban Region and UM invest 6 million in collaboration
Heerlen grants a one-time contribution of €1,478,050 to Maastricht University as part of the Regio Deal application ‘Fundament onder UM-onderwijs in Heerlen’. This amount comes from the Fonds Economische Structuurversterking (FES). The funding will help establish university education facilities in...
